Pharmaceutical Technology Europe-12-01-2008

Pharmaceutical Technology Europe

The long awaited revision

December 01, 2008

Regulatory Report

20

12

The closing date for comments to be received by the US Pharmacopeia (USP) for proposed revisions to Chapter , which deals with analysis of heavy metals, is 15 December 2008. The USP has been working towards for approximately 4 years and the task has not been easy.

The dating agency

December 01, 2008

Spotlight

20

12

Hundreds of pharma–biotech deals have been announced during 2008 and many of these probably began at biopartnering conferences. Susan Aldridge examines some of this year's big buyouts and mergers.

VC: virtuous or vampire capital?

December 01, 2008

Biotech business

20

12

It is a universally acknowledged truth that a biotech start-up in possession of little fortune must be in want of venture capital (VC). Perhaps less well acknowledged, however, is that VC investors operate in a way consistent with being rational economic entities...

Assuring sterility with ASTM F 838-83

December 01, 2008

Manufacturing & Processing

20

12

Although realized in 1983, ASTM's standrad test method for determining bacterial retention of membrane filters used for liquid filtration is still hugely beneficial to today's pharmaceutical industry.

Partnership power

December 01, 2008

Business Talk

20

12

TranScrip Partners' Flic Gabbay explains why an approach that provides expertise on an 'as needed basis' is flourishing.